LEF1, β-Catenin and MTDH contribute to tumorigenesis of hepatocellular carcinoma via enhancement on the tumor-initiating cell-like properties
碩士 === 國立陽明大學 === 臨床醫學研究所 === 100 === Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related death in the world and the second one in Taiwan. Only about 20-30% of HCC patients are diagnosed at early stage to receive curative treatment (tumor resection, liver transplantation or l...
Main Authors: | Hsin-Yu Tseng, 曾心渝 |
---|---|
Other Authors: | Jaw-Ching Wu |
Format: | Others |
Language: | en_US |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/23333029945275650018 |
Similar Items
-
Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma
by: Harshul Pandit, et al.
Published: (2018-08-01) -
Expression and meaning of MTDH and β-catenin in ocular adnexal lymphoma
by: Yan Gao, et al.
Published: (2017-02-01) -
Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma
by: Hor-Yue Tan, et al.
Published: (2018-06-01) -
Role of MTDH, FOXM1 and microRNAs in Drug Resistance in Hepatocellular Carcinoma
by: Xiangbing Meng, et al.
Published: (2014-07-01) -
circ_0003418 Inhibits Tumorigenesis And Cisplatin Chemoresistance Through Wnt/β-Catenin Pathway In Hepatocellular Carcinoma
by: Chen H, et al.
Published: (2019-11-01)